Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  ACB | T.ACB.WS.U

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by Raguu17on May 15, 2018 11:14pm
54 Views
Post# 28036766

RE:RE:Share Price

RE:RE:Share Price1. They never claimed to have it ready for October. This is some more of your bs.

2. This is according to you. You know very little. What LP is ready for rec today? The industry is not ready today. The government is not ready today. Then you compound an assunption on your previous bs. 

3. They promised what to CMED. This is what this is all really about. You are still crying the blues because you feel you should have gotten more. The enitre industry went on a ride. Cali legalized. thats it. You bet on a CEO that was against rec mj. That is about all I need to say about this. 

4. LEAF doesn't have CEO against rec MJ trying to keep HIS company. You do understand it was your CMED wizard CEO that was supposed secure you the best deal. This is a MERGER. BIG difference.

You can't see anything. You are on simply full of sh!t. If you have lost interest why are you here? Oh yeah that trolling game you play. Trailing the bs as thick as you can. 

I want you to sell. Sell it all. Buy APH and enjoy. I am sure they appreciate your brilliance over there. Do you supply them with wonderful lists of strains as well? Awesome!! 


You are a total troll. You know that though. 


MartialArts wrote: That will be in July and ACB needs only 50%.  Most LEAF investors have done zero due diligence on ACB.  As they do that, they will see that:

1. Failed promised.  The flagship Aurora SKY, due for completion October 2017 is so far behind schedule, management has stopped giving completion estimates.

2. Not ready for recreational.  Yes, they promise to have the leading production in 2019 but given the track record, we can assume that will be yet another failed promise.

3. They promised an implied value of $14+ ACB for CMED holders, some of us managed to get that as we sold CMED just after the announcement but the ride down from there was bad.  I feel bad for any CMED holders expecting to get $14 ACBs and ending up at less than $8 and going for another "ride".  The sad part is the novices are the first to have a hard time to cut their loses. They are trapped.

4. LEAF are being sold the same BS story of $29 implied value and when they wake up going "wait, why is it traded at just $25". That because the two stocks are tied at 1 to 3.575 as as LEAF and ACB shareholders bail for other stock with their hard cash, the selling pressure will mount.  Post completion of the deal (August and September), the stock will have been a laggard as the rest of the pack benefits from legalization and then, only then, will valuations be better.

I can see the master game plan by Aurora Management.  Long term sure.  Short term, you have to be in love with a stock to stay knowing it's going to underperform for 4-5 months at minimum.

I hope someone can convince me not to sell my small remaining portion in ACB.  Please do it based on facts.


Bullboard Posts